ANGLE plc (LON:AGL – Get Free Report) shares crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 13.39 ($0.17) and traded as low as GBX 7.81 ($0.10). ANGLE shares last traded at GBX 8.25 ($0.11), with a volume of 834,348 shares.
Wall Street Analyst Weigh In
Separately, Berenberg Bank reaffirmed a “buy” rating and set a GBX 70 ($0.91) target price on shares of ANGLE in a research report on Thursday, September 26th.
ANGLE Stock Performance
About ANGLE
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.
See Also
- Five stocks we like better than ANGLE
- How to Calculate Stock Profit
- Dot Ai IPO: CEO Ed Nabrotzky Shares Vision for Logistics Future
- What is Short Interest? How to Use It
- The Hottest Markets to Watch After the Fed’s 25 Bps Rate Cut
- Why Invest in High-Yield Dividend Stocks?
- The Top 5 Performing S&P 500 Stocks YTD in 2024
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.